Ronald de Wit - Biography#

Professor Ronald de Wit is Medical Oncologist, and full professor at the Erasmus MC Cancer Institute. He earned his medical degree at the University of Amsterdam and built his career at the Erasmus MC since 1990. Prof de Wit is member of a wide range of professional societies and committees and is serving as Faculty and Program Committee Member of both the American Society of Clinical Oncology (ASCO) and the European Society of Medical Oncology (ESMO). He is lecturer at the ESMO-Asia, ESMO-Americas, ESMO-Africa, and ESMO-Middle East annual meetings.

His research focus is Genito-Urinary Oncology. He is former chairman of the EORTC Group Chemotherapy Subcommittee and initiated and led randomized studies in testicular cancer, prostate, renal and bladder cancer. He co-chaired phase 3 registration trials, ranging from chemotherapy and AR targeted agents in prostate cancer, to checkpoint inhibition (PD-1) trials in bladder cancer. He is involved in a wide variety of ongoing clinical studies, was the principal investigator for the practice changing phase 3 CARD study, and serves on Industry Advisory Board Committees, as well as Data Monitoring Committees. Prof de Wit is collaborating with the Departments of Urology and Translational Pathology in preclinicap and clinical translational research. He launched and is Chairman of the Dutch Uro-Oncology Study Group (www.stichtingDUOS.nl), comprising 27 Academic and supraregional Hospitals in the Netherlands. His publications include over 350 papers and book chapters.